GLP-1 and Fertility: Emerging Evidence for Women With Obesity, Insulin Resistance, and PMOS GLP-1 fertility research in women with PMOS and insulin resistance shows consistent improvements in ovulation, menstrual regularity, and androgen levels
Some programs focus only on selling medication
Optimal dosing varies based on body weight, body composition goals, and individual metabolic factors
ER is recommended for once-weekly injection, which has major advantages in dealing patients who routinely forget to take their medication (Scott, 2012)
Acute insulin application in the ventral tegmental area in vitro diminishes somatodendritic dopamine levels via increased dopamine transporter activity, mediated by PI3K and mammalian target of rapamycin (mTOR) signaling pathways [90]
A recent study demonstrated that neuroinflammation could evoke depressive symptoms such as anhedonia and motor retardation (Felger and Treadway, 2017)